Flumazenil
Who holds supplier records for Flumazenil? 6 organisations hold a current record for Flumazenil: an active US FDA Type II Drug Master File or a CEP. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Taiwan (1), Netherlands (1) and Israel (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Flumazenil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/flumazenil
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Flumazenil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hubei Haosun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 17971 · latest filing Dec 2004
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 15592 · latest filing Aug 2001
- HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDChinaActive DMF 19723 · latest filing Aug 2006
- PERRIGO API LTDActive DMF 15692 · latest filing Oct 2001
- NetherlandsCEP Company GMP cert on record
- IsraelCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Flumazenil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou | CN | CEP 2008-121 - Rev 03 Flumazenil | Jan 2025 | Inspected Aug 2024 Belgium |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2003-237 - Rev 07 Flumazenil | Oct 2024 | — |
| SYNTHON B.V. Nijmegen | NL | CEP 2015-253 - Rev 01 Flumazenil | Sept 2024 | Inspected May 2024 Netherlands |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2006-114 - Rev 01 Flumazenil | Sept 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Flumazenil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL407).
Chemical identity
- IUPAC name
- ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- Canonical SMILES
- CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C
- InChIKey
- OFBIFZUFASYYRE-UHFFFAOYSA-N
- Synonyms
- Anexate, Flumazenil, Flumazepil, Lanexat, Mazicon, NSC-759193, RO-15-1788, RO-151788, RO 15-1788/000, RO-15-1788/000, RO-151788000, RO-1722
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Benzodiazepine Antagonist
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Flumazenil?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Flumazenil: Hubei Haosun Pharmaceutical Co., Ltd. (China), SCINOPHARM TAIWAN LTD (Taiwan), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China), PERRIGO API LTD, Synthon (Netherlands) and WAVELENGTH ENTERPRISES LTD (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Flumazenil Drug Master Files are active?
Hubei Haosun Pharmaceutical Co., Ltd. (DMF 17971), SCINOPHARM TAIWAN LTD (DMF 15592), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (DMF 19723) and PERRIGO API LTD (DMF 15692). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Flumazenil have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Flumazenil on the EDQM register, including HUBEI HAOSUN PHARMACEUTICAL CO., LTD. Ezhou (CN), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL), SYNTHON B.V. Nijmegen (NL) and SCINOPHARM TAIWAN LTD. Shan-Hua (TW). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Flumazenil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Flumazenil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.